GL1X · GenesisL1 explorer

Research workbench

Plasmodium vivax cytoplasmic phenylalanyl-tRNA synthetase in complex with BRD1389

Analyse Plasmodium vivax cytoplasmic phenylalanyl-tRNA synthetase in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7BY6
Type
protein
Length
905 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phenylalanyl-tRNA synthetase beta chain, putative
EC
6.1.1.20
UniProt
A5K9S0, A5K464
Ligands
FB9, MG
Pockets
15 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhenylalanyl-tRNA synthetase beta chain, putative (EC 6.1.1.20)protein29930% helix, 23% strandA5K9S0
BPhenylalanyl-tRNA synthetase beta chain, putative (EC 6.1.1.20)protein60629% helix, 24% strandA5K464

Ligands and binding sites

  • FB9 · (3S,4R,8R,9R,10S)-N-(4-cyclopropyloxyphenyl)-10-(methoxymethyl)-3,4-bis(oxidanyl)-9-[4-(2-phenylethynyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111860.820.83143FB9
210680.810.82109empty
31350.790.9623empty
4570.620.9220empty
51070.610.8723empty

Interfaces

1 interface between chains.

  • A–B · 2962 Ų buried · 33 hydrogen bonds · protein-protein

Compared structures

  • 7BY6 · Plasmodium vivax cytoplasmic Phenylalanyl-tRNA synthetase in complex with BRD1389 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.